Market Closed -
Other stock markets
|
After market 11:20:00 am | |||
2,041 DKK | +0.74% | 2,041 | 0.00% |
May. 15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
May. 15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Bearish |
Resistance | 2,086.00 | 2,258.00 | 2,295.00 |
Spread/Res. | -2.16% | -9.61% | -11.07% |
Spread/Supp. | +6.55% | +10.06% | +7.28% |
Support | 1,915.50 | 1,854.50 | 1,902.50 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S